← Open Payments lookup

LAURIE REEVES: Open Payments

NPI 1942510698 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$946 in 40 payments from 20 companies in 2025. Trend: 2023 $1,178 · 2024 $768 · 2025 $946

Food & beverage: $946
CompanyPaymentsAmount
UCB, Inc.12$181
SHIELD THERAPEUTICS INC1$118
Teva Pharmaceuticals USA, Inc.4$96
Vanda Pharmaceuticals Inc.2$69
Novo Nordisk Inc3$53
Otsuka America Pharmaceutical, Inc.2$47
Axsome Therapeutics, Inc.2$46
ABBVIE INC.2$40
GlaxoSmithKline, LLC.1$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34

Products named: ACCRUFER, Fintepla, Briviact, FANAPT, AUSTEDO XR, REXULTI, Auvelity, EMBLAVEO.

Industry payments across CA — which companies pay providers there.